A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine
Hankaniemi, M. M., Stone, V. M., Sioofy-Khojine, A.-B., Heinimäki, S., Marjomäki, V., Hyöty, H., Blazevic, V., Laitinen, O. H., Flodström-Tullberg, M., & Hytönen, V. P. (2019). A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine. Vaccine, 37(40), 5962-5971. https://doi.org/10.1016/j.vaccine.2019.08.037
© 2019 The Author(s).
Type B Coxsackieviruses (CVBs) belong to the enterovirus genus, and they cause both acute and chronic diseases in humans. CVB infections usually lead to flu-like symptoms but can also result in more serious diseases such as myocarditis, aseptic meningitis and life-threatening multi-organ infections in young infants. Thus, CVBs have long been considered as important targets of future vaccines. We have previously observed CVB1 capsid disintegration and virus concentration decrease with 12-day long formalin inactivation protocol. Here a scalable ion exchange chromatography purification method was developed, and purified CVB1 was inactivated with UV-C or formalin. Virus morphology and concentration remained unchanged, when the UV (2 min) or formalin (5 days) inactivation were performed in the presence of tween80 detergent. The concentration of the native and UV inactivated CVB1 remained constant at 4 °C during a six months stability study, whereas the concentration of the formalin inactivated vaccine decreased 29% during this time. UV treatment decreased, whereas formalin treatment increased the thermal stability of the capsid. The formalin inactivated CVB1 vaccine was more immunogenic than the UV inactivated vaccine; the protective neutralizing antibody levels were higher in mice immunized with formalin inactivated vaccine. High levels of CVB1 neutralizing antibodies as well as IgG1 antibodies were detected in mice that were protected against viremia induced by experimental CVB1 infection. In conclusion, this study describes a scalable ion exchange chromatography purification method and optimized 5-day long formalin inactivation method that preserves CVB1 capsid structure and immunogenicity. Formalin treatment stabilizes the virus particle at elevated temperatures, and the formalin inactivated vaccine induces high levels of serum IgG1 antibodies (Th2 type response) and protective levels of neutralizing antibodies. Formalin inactivated CVB vaccines are promising candidates for human clinical trials. ...
Publication in research information system
MetadataShow full item record
Additional information about fundingThe research was funded by the Academy of Finland (projects 1309455 and 288671), Business Finland (project HERDIAB: 1843/31/2014), the Swedish Child Diabetes Foundation, Karolinska Institutet including the Strategic Research Program in Diabetes and Jane and Aatos Erkko Foundation.
Showing items with similar title or keywords.
Hankaniemi, Minna M.; Stone, Virginia M.; Andrejeff, Tanja; Heinimäki, Suvi; Sioofy-Khojine, Amir-Babak; Marjomäki, Varpu; Hyöty, Heikki; Blazevic, Vesna; Flodström-Tullberg, Malin; Hytönen, Vesa P.; Laitinen, Olli H. (Elsevier, 2019)Type B Coxsackieviruses (CVBs) are a common cause of acute and chronic myocarditis, dilated cardiomyopathy and aseptic meningitis. However, no CVB-vaccines are available for human use. We have previously produced virus-like ...
Hankaniemi, Minna M.; Baikoghli, Mo A.; Stone, Virginia M.; Xing, Li; Väätäinen, Outi; Soppela, Saana; Sioofy-Khojine, Amirbabak; Saarinen, Niila V. V.; Ou, Tingwei; Anson, Brandon; Hyöty, Heikki; Marjomäki, Varpu; Flodström-Tullberg, Malin; Cheng, R. H.; Hytönen, Vesa P.; Laitinen, Olli H. (MDPI, 2020)Coxsackievirus B (CVB) enteroviruses are common pathogens that can cause acute and chronic myocarditis, dilated cardiomyopathy, aseptic meningitis, and they are hypothesized to be a causal factor in type 1 diabetes. The ...
A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates Stone, V. M.; Hankaniemi, M. M.; Laitinen, O. H.; Sioofy-Khojine, A. B.; Lin, A.; Diaz Lozano, I. M.; Mazur, M. A.; Marjomäki, V.; Loré, K.; Hyöty, H.; Hytönen, V. P.; Flodström-Tullberg, M. (American Association for the Advancement of Science, 2020)Coxsackievirus B (CVB) enteroviruses are common human pathogens known to cause severe diseases including myocarditis, chronic dilated cardiomyopathy, and aseptic meningitis. CVBs are also hypothesized to be a causal factor ...
Runtuvuori, Anniina (2017)Coxsackievirusryhmä B (CVB) kuuluu Picornaviridae -heimoon ja Enterovirus-sukuun. Pikornavirukset ovat pieniä, halkaisijaltaan noin 30 nm, vaipattomia ja ikosahedraalisia viruksia. Viimeaikaiset tutkimukset ovat osoittaneet, ...
Kalander, Kerttu (2021)Enterovirusten sukuun sisältyy suuri määrä viruslajeja, jotka aiheuttavat tyypillisesti lieviä flunssan oireita, mutta niiden tiedetään myös johtavan vakavampiin akuutteihin ja kroonisiin tulehduksiin. Ne on myös yhdistetty ...